UofL receives $16M to train more primary care physicians for underserved communities

The University of Louisville has received $16 million to help increase Kentuckians’ access to health care, particularly in underserved rural and urban areas.

Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s disease

Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.

April 25, 2024

Novartis, Ionis will work together again in the next-generation cardio space

Novartis is once again teaming up with Ionis on a next-generation siRNA cardio drug, picking up another shot in an increasingly competitive space. The deal

August 4, 2023

Coya stretches lead drug’s development to Parkinson’s and dementia – Pharmaceutical Technology

Share this article COYA 302 is an investigational combination drug made up of a low dose interleukin 2 (IL-2) drug and a CTLA4 Ig fusion

January 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.